PALI - Why Palisade Bio Stock Is Up Today | Benzinga
Palisade Bio, Inc. (NASDAQ:PALI) shares are trading higher Tuesday after the company entered into a collaboration with Strand Life Sciences.
The Details:
Palisade Bio said its collaboration with Strand Life Sciences is aimed at advancing precision medicine for ulcerative colitis (UC) therapy and provides the company access to advanced bioinformatics tools vital for understanding complex disease pathways and predicting responses to PDE4 inhibitors.
“Our partnership with Strand Life Sciences signifies a pivotal advancement in our mission to revolutionize UC treatment,” ...